|
1
|
Brianti P, De Flammineis E and Mercuri SR:
Review of HPV-related diseases and cancers. New Microbiol.
40:80–85. 2017.PubMed/NCBI
|
|
2
|
Gupta S, Kumar P and Das BC: HPV:
Molecular pathways and targets. Curr Probl Cancer. 42:161–174.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Oyervides-Muñoz MA, Pérez-Maya AA,
Rodríguez-Gutiérrez HF, Gómez-Macias GS, Fajardo-Ramírez OR,
Treviño V, Barrera-Saldaña HA and Garza-Rodríguez ML: Understanding
the HPV integration and its progression to cervical cancer. Infect
Genet Evol. 61:134–144. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kalińska-Bienias A, Kowalewski C and
Majewski S: The EVER genes-the genetic etiology of carcinogenesis
in epidermodysplasia verruciformis and a possible role in
non-epidermodysplasia verruciformis patients. Postepy Dermatol
Alergol. 33:75–80. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lazarczyk M, Pons C, Mendoza JA, Cassonnet
P, Jacob Y and Favre M: Regulation of cellular zinc balance as a
potential mechanism of EVER-mediated protection against
pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp
Med. 205:35–42. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Arnold AW, Burger B, Kump E, Rufle A,
Tyring SK, Kempf W, Häusermann P and Itin PH: Homozygosity for the
c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two
sisters with epidermodysplasia verruciformis Lewandowsky-Lutz
originally described by Wilhelm Lutz. Dermatology. 222:81–86.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hohenstein E, Rady PL, Hergersberg M,
Huber AR, Tyring SK, Bregenzer T, Streit M and Itin P:
Epidermodysplasia verruciformis in a HIV-positive patient
homozygous for the c917A→T polymorphism in the TMC8/EVER2 gene.
Dermatology. 218:114–118. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zuo YG, Ma D, Zhang Y, Qiao J and Wang B:
Identification of a novel mutation and a genetic polymorphism of
EVER1 gene in two families with epidermodysplasia verruciformis. J
Dermatol Sci. 44:153–159. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Castro FA, Ivansson EL, Schmitt M,
Juko-Pecirep I, Kjellberg L, Hildesheim A, Gyllensten UB and
Pawlita M: Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants
to cervical cancer susceptibility. Int J Cancer. 130:349–355.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Antonsson A, Law MH, Neale RE, Coman WB
and Pryor DI: Study of Digestive Health (SDH). Porceddu SV and
Whiteman DC: Variants of EVER1 and EVER2 (TMC6 and TMC8) and human
papillomavirus status in patients with mucosal squamous cell
carcinoma of the head and neck. Cancer Causes Control. 27:809–815.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liang C, Kelsey KT, McClean MD,
Christensen BC, Marsit CJ, Karagas MR, Waterboer T, Pawlita M and
Nelson HH: A coding variant in TMC8 (EVER2) is associated with high
risk HPV infection and head and neck cancer risk. PLoS One.
10(e0123716)2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Patel AS, Karagas MR, Pawlita M, Waterboer
T and Nelson HH: Cutaneous human papillomavirus infection, the
EVER2 gene and incidence of squamous cell carcinoma: A case-control
study. Int J Cancer. 122:2377–2379. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hampras SS, Rollison DE, Tommasino M,
Gheit T, Schabath MB, Messina JL, Fenske NA, Cherpelis BS, Sondak
VK, Iannacone MR, et al: Genetic variations in the
epidermodysplasia verruciformis (EVER/TMC) genes, cutaneous human
papillomavirus infection and squamous cell carcinoma of the skin.
Br J Dermatol. 173:1532–1535. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pavlidou E, Daponte A, Egea R, Dardiotis
E, Hadjigeorgiou GM, Barbadilla A and Agorastos T: Genetic
polymorphisms of FAS and EVER genes in a Greek population and their
susceptibility to cervical cancer: A case control study. BMC
Cancer. 16(923)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang SS, Gonzalez P, Yu K, Porras C, Li Q,
Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, et al:
Common genetic variants and risk for HPV persistence and
progression to cervical cancer. PLoS One. 5(e8667)2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Iorga L, Dragos Marcu R, Cristina Diaconu
C, Maria Alexandra Stanescu A, Pantea Stoian A, Liviu Dorel
Mischianu D, Surcel M, Bungau S, Constantin T, Boda D, et al:
Penile carcinoma and HPV infection (review). Exp Ther Med.
20:91–96. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Srinivas V, Morse MJ, Herr HW, Sogani PC
and Whitmore WF Jr: Penile cancer: Relation of extent of nodal
metastasis to survival. J Urol. 137:880–882. 1987.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hakenberg OW, Compérat EM, Minhas S,
Necchi A, Protzel C and Watkin N: EAU guidelines on penile cancer:
2014 update. Eur Urol. 67:142–150. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kroon BK, Horenblas S and Nieweg OE:
Contemporary management of penile squamous cell carcinoma. J Surg
Oncol. 89:43–50. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Alemany L, Cubilla A, Halec G, Kasamatsu
E, Quirós B, Masferrer E, Tous S, Lloveras B, Hernández-Suarez G,
Lonsdale R, et al: Role of human papillomavirus in penile
carcinomas worldwide. Eur Urol. 69:953–961. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Emmanuel A, Nettleton J, Watkin N and
Berney DM: The molecular pathogenesis of penile carcinoma-current
developments and understanding. Virchows Arch. 475:397–405.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-part A: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brierley JD, Gospodarowicz MK and
Wittekind C (eds): TNM classification of malignant tumours. 8th
edition. Wiley Blackwell, United Kingdom, 2017.
|
|
24
|
Stoehr R, Weisser R, Wendler O, Giedl J,
Daifalla K, Gaisa NT, Richter G, Campean V, Burger M, Wullich B and
Hartmann A: P53 codon 72 polymorphism and risk for squamous cell
carcinoma of the penis: A caucasian case-control study. J Cancer.
9:4234–4241. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Weyerer V, Schneckenpointner R, Filbeck T,
Burger M, Hofstaedter F, Wild PJ, Fine SW, Humphrey PA, Dehner LP,
Amin MB, et al: Immunohistochemical and molecular characterizations
in urothelial carcinoma of bladder in patients less than 45 years.
J Cancer. 8:323–331. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
de Roda Husman AM, Walboomers JM, van den
Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5
and GP6 elongated at their 3'ends with adjacent highly conserved
sequences improves human papillomavirus detection by PCR. J Gen
Virol. 76:1057–1062. 1995.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lin CY, Chao A, Yang YC, Chou HH, Ho CM,
Lin RW, Chang TC, Chiou JY, Chao FY, Wang KL, et al: Human
papillomavirus typing with a polymerase chain reaction-based
genotyping array compared with type-specific PCR. J Clin Virol.
42:361–367. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Şahiner F, Kubar A, Yapar M, Şener K, Dede
M and Gümral R: Detection of major HPVs by a new multiplex
real-time PCR assay using type-specific primers. J Microbiol
Methods. 97:44–50. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kalinska-Bienias A, Kowalewski C,
Kostrzewa G, Malejczyk M, Ploski R and Majewski S: Possible
association between actinic keratosis and polymorphism rs7208422
(c.917A→T, p.N306l) of EVER2 gene in non-epidermodysplasia
verruciformis patients. J Invest Dermatol. 134(S22)2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Burger B, Spörri I, Stegmann DA, De
Mesmaker J, Schaub S, Itin PH, Steiger J and Arnold AW: Risk of
cutaneous squamous cell carcinoma development in renal transplant
recipients is independent of TMC/EVER alterations. Dermatology.
231:245–252. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hemmat N and Baghi HB: Human
papillomavirus E5 protein, the undercover culprit of tumorigenesis.
Infect Agent Cancer. 13(31)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
de Jong SJ, Crequer A, Matos I, Hum D,
Gunasekharan V, Lorenzo L, Jabot-Hanin F, Imahorn E, Arias AA,
Vahidnezhad H, et al: The human CIB1-EVER1-EVER2 complex governs
keratinocyte-intrinsic immunity to β-papillomaviruses. J Exp Med.
215:2289–2310. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lazarczyk M, Cassonnet P, Pons C, Jacob Y
and Favre M: The EVER proteins as a natural barrier against
papillomaviruses: A new insight into the pathogenesis of human
papillomavirus infections. Microbiol Mol Biol Rev. 73:348–370.
2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Scarth JA, Patterson MR, Morgan EL and
Macdonald A: The human papillomavirus oncoproteins: A review of the
host pathways targeted on the road to transformation. J Gen Virol.
102(001540)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kalinska-Bienias A, Kostrzewa G, Malejczyk
M, Ploski R and Majewski S: Possible association between actinic
keratosis and the rs7208422 (c.917A→T, p.N306l) polymorphism of the
EVER2 gene in patients without epidermodysplasia verruciformis.
Clin Exp Dermatol. 40:318–323. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
McDermott DF, Gammon B, Snijders PJ, Mbata
I, Phifer B, Howland Hartley A, Lee CC, Murphy PM and Hwang ST:
Autosomal dominant epidermodysplasia verruciformis lacking a known
EVER1 or EVER2 mutation. Pediatr Dermatol. 26:306–310.
2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Quinn AG, Sikkink S and Rees JL: Basal
cell carcinomas and squamous cell carcinomas of human skin show
distinct patterns of chromosome loss. Cancer Res. 54:4756–4759.
1994.PubMed/NCBI
|
|
39
|
Li J, Wang K, Gao F, Jensen TD, Li ST,
DeAngelis PM, Kølvraa S, Proby C, Forslund O, Bolund L and Clausen
OP: Array comparative genomic hybridization of keratoacanthomas and
squamous cell carcinomas: Different patterns of genetic aberrations
suggest two distinct entities. J Invest Dermatol. 132:2060–2066.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Busso-Lopes AF, Marchi FA, Kuasne H,
Scapulatempo-Neto C, Trindade-Filho JC, de Jesus CM, Lopes A,
Guimarães GC and Rogatto SR: Genomic profiling of human penile
carcinoma predicts worse prognosis and survival. Cancer Prev Res
(Phila). 8:149–156. 2015.PubMed/NCBI View Article : Google Scholar
|
